Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Generic competition pounds Sanofi-Aventis

Article Abstract:

Second-quarter net profit for French pharmaceutical firm Sanofi-Aventis SA decreased by 6.3% to reach 1.68 bil euro, due in part to competition from generic medications. Net sales dropped 2% to reach 6.94 bil.

Author: Berton, Elena
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Sanofi's profit falls 2.6%

Article Abstract:

First-quarter net profit for pharmaceutical company Sanofi-Aventis S.A. dropped 2.6% to $2.87 bil, while net sales rose by 2%. Sales gains for individual drug products are presented.

Author: Berton, Elena
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Pharmaceutical industry, France, Company sales and earnings, Company earnings/profit, SNY, Sanofi-Aventis S.A., Financial report
Similar abstracts:
  • Abstracts: Endesa's net profit drops 40% on absence of year-earlier gains. Endesa's earnings jump 88%; holders to decide on rival bids
  • Abstracts: Scottish Power posts profit drop, prices lift revenue. E.On's net profit jumps 50% on growth in foreign markets
  • Abstracts: Ryanair's posts 26% rise in net amid surging nonticket revenue. Ryanair net drops on high fuel costs
  • Abstracts: Finding the most preferred alliance structure between banks and insurance companies. A financial alliance compromise between executives and supervisory authorities
  • Abstracts: Nissan's profit plunges 54%: job cuts, new models lead recovery plan; sales target delayed
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.